Shared Care for Adults with Sickle Cell Disease: An Analysis of Care from Eight Health Systems.
electronic medical record
primary care
secondary data analysis
shared care
sickle cell disease
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
02 Aug 2019
02 Aug 2019
Historique:
received:
11
07
2019
revised:
30
07
2019
accepted:
31
07
2019
entrez:
7
8
2019
pubmed:
7
8
2019
medline:
7
8
2019
Statut:
epublish
Résumé
Adult sickle cell disease (SCD) patients frequently transition from pediatric hematology to adult primary care. We examined healthcare utilization for adult patients with SCD with shared care between hematologists and primary care providers (PCP). We analyzed the OneFlorida Data Trust, a centralized data repository of electronic medical record (EMR) data from eight different health systems in Florida. The number of included adults with SCD was 1147. We examined frequent hospitalizations and emergency department (ED) visits by whether the patient had shared care or single specialty care alone. Most patients were seen by a PCP only (30.4%), followed by both PCP and hematologist (27.5%), neither PCP nor hematologist (23.3%), and hematologist only (18.7%). For patients with shared care versus single specialist care other than hematologist, the shared care group had a lower likelihood of frequent hospitalizations (OR 0.63; 95% CI 0.43-0.90). Similarly, when compared to care from a hematologist only, the shared care group had a lower likelihood of frequent hospitalizations (OR 0.67; 95% CI 0.47-0.95). There was no significant relationship between shared care and ED use. When patients with SCD have both a PCP and hematologist involved in their care there is a benefit in decreased hospitalizations.
Identifiants
pubmed: 31382365
pii: jcm8081154
doi: 10.3390/jcm8081154
pmc: PMC6723540
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Centers for Disease Control and Prevention
ID : CDC-RFA-DD14-1406
Pays : United States
Références
Pediatrics. 2001 Oct;108(4):906-12
pubmed: 11581443
Medicine (Baltimore). 2005 Nov;84(6):363-76
pubmed: 16267411
Am J Manag Care. 2008 Apr;14(4):213-24
pubmed: 18402514
Pediatrics. 2009 Jan;123(1):407-12
pubmed: 19117908
Blood. 2010 Apr 29;115(17):3447-52
pubmed: 20194891
JAMA. 2010 Apr 7;303(13):1288-94
pubmed: 20371788
JAMA. 2010 Jul 28;304(4):408-9; author reply 409
pubmed: 20664039
Am J Hematol. 2011 Jan;86(1):116-20
pubmed: 21061308
Expert Rev Hematol. 2010 Jun;3(3):255-60
pubmed: 21082977
JRSM Short Rep. 2012 Nov;3(11):78
pubmed: 23323196
Public Health Rep. 2013 Mar-Apr;128(2):110-6
pubmed: 23450875
Fam Med. 2013 Jul-Aug;45(7):463-74
pubmed: 23846965
Br J Gen Pract. 2013 Dec;63(617):e798-806
pubmed: 24351495
J Gen Intern Med. 2014 Dec;29(12):1657-62
pubmed: 25205621
Anemia. 2015;2015:853835
pubmed: 25793124
South Med J. 2015 Sep;108(9):531-6
pubmed: 26332477
Public Health Rep. 2016 Jan-Feb;131(1):108-16
pubmed: 26843676
Public Health Rep. 2016 Mar-Apr;131(2):367-75
pubmed: 26957672
Blood. 2016 Sep 8;128(10):1436-8
pubmed: 27439910
Pediatr Blood Cancer. 2017 Jun;64(6):
pubmed: 28000344
J Rare Dis Res Treat. 2017;2(4):39-45
pubmed: 29202133
Am J Hematol. 2019 May;94(5):E138-E141
pubmed: 30773675
BMJ. 1994 Apr 23;308(6936):1051-2
pubmed: 8173418